Dissemination research in cancer control: where are we and where should we go?

被引:39
|
作者
Bowen, Deborah J. [1 ]
Sorensen, Glorian [2 ,3 ]
Weiner, Bryan J. [4 ]
Campbell, Marci [5 ,6 ]
Emmons, Karen [2 ,3 ]
Melvin, Cathy [7 ]
机构
[1] Boston Univ, Sch Publ Hlth, Social & Behav Sci Dept, Boston, MA 02118 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA
[5] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[7] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA
关键词
Dissemination; Implementation; Diffusion; Translation; RANDOMIZED CONTROLLED-TRIAL; HEALTH-PROMOTION; PUBLIC-HEALTH; EXTERNAL VALIDITY; PHYSICAL-ACTIVITY; COMMUNITY; INTERVENTIONS; IMPLEMENTATION; TRANSLATION; BEHAVIOR;
D O I
10.1007/s10552-009-9308-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dissemination of evidence-based programs and policies is a critical final step in reducing the burden of cancer in the general public. Yet, we have not been fully successful to date in improving clinical or public health practice by disseminating programs found to be effective in research. Therefore, research is needed into the dissemination process and outcomes to enable better efforts in the future. This paper explores the definitions and models used for dissemination, the designs of dissemination studies, and possible research questions in dissemination research, all focused on cancer prevention and control. We hope that this paper will encourage dissemination research in our field.
引用
收藏
页码:473 / 485
页数:13
相关论文
共 50 条
  • [31] Community Deception in Networks: Where We Are and Where We Should Go
    Fionda, Valeria
    Pirro, Giuseppe
    COMPLEX NETWORKS & THEIR APPLICATIONS X, VOL 2, 2022, 1016 : 144 - 155
  • [32] The burden of blood pressure: Where are we and where should we go?
    Hamet, P
    CANADIAN JOURNAL OF CARDIOLOGY, 2000, 16 (12) : 1483 - 1487
  • [33] Uterine fibroid embolization: where are we and where should we go?
    Pelage, JP
    Fauconnier, A
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 25 (06) : 527 - 534
  • [34] Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?
    Martin, R
    Stürzebecher, CS
    McFarland, HF
    NATURE IMMUNOLOGY, 2001, 2 (09) : 785 - 788
  • [35] Standard treatment in anal cancer: where do we stand and where should we go?
    Muirhead, R.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S250 - S250
  • [36] Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
    Banz-Jansen, Constanze
    Helweg, Laureen P.
    Kaltschmidt, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [37] Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go
    Gonzalez, Carlos A.
    Agudo, Antonio
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (04) : 745 - 753
  • [38] ISNT THIS WHERE WE SHOULD GO
    FLAHERTY, JA
    SMPTE JOURNAL, 1994, 103 (01): : 41 - 44
  • [39] Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go
    Li, Song
    Jia, Congcong
    Li, Tianbai
    Le, Weidong
    NEUROSCIENCE BULLETIN, 2021, 37 (12) : 1735 - 1744
  • [40] PSYCHOTHERAPY-RESEARCH - WHERE ARE WE AND WHERE SHOULD WE GO - WILLIAMS,JBW, SPITZER,RL
    FRANK, JD
    PHILLIPS, JS
    CONTEMPORARY PSYCHOLOGY, 1985, 30 (09): : 681 - 683